ArticleFrontiers in immunology2024

EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation.

Rachel S Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.